Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
Multiple Sclerosis International · 2011
DOI: 10.1155/2011/315406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis International, 2011. Verfasst von Melissa M Gresle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Biomarkers of axonal degeneration have the potential to improve our capacity to predict and monitor neurological outcome in multiple sclerosis (MS) patients. Neurofilament proteins, one of the major proteins expressed within neurons and axons, have been detected in cerebrospinal fluid and blood samples from MS patients and are now being actively investigated for their utility as prognostic indicators of disease progression in MS. In this paper, we summarize the current literature on neurofilament structure, assembly, and degeneration and discuss their potential utility as biomarkers for monitoring neurological decline in MS. We also discuss the need to further develop sensitive methods for assaying neurofilaments in blood to improve clinical applicability.
Autor:innen und Institutionen
- Department of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia.
Zitieren
APA
Gresle, M. M., Butzkueven, H., & Shaw, G. (2011). Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis. Multiple Sclerosis International. https://doi.org/10.1155/2011/315406
Vancouver
Gresle MM, Butzkueven H, Shaw G. Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis. Multiple Sclerosis International. 2011. doi:10.1155/2011/315406
BibTeX
@article{Gresle2011,
author = {Gresle, Melissa M and Butzkueven, Helmut and Shaw, Gerry},
title = {Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis},
journal = {Multiple Sclerosis International},
year = {2011},
doi = {10.1155/2011/315406}
}
EUVIMED